COURSE DIRECTOR
Yi Lin, MD, PhD

DESCRIPTION
This is a course intended for Mayo personnel.  It is a multidisciplinary forum designed to enhance the practice and ensure excellence in all aspects of Cell Therapy.  We also discuss controversial cases as part of a patient selection process, presenting the data and literature in support and against proceeding with CAR-T cell therapy for a specific circumstance. In attendance:  MD Providers, APP/NP, Nursing, Pharmacy, Social work, and study coordinators.

TARGET AUDIENCE
This series is intended for Allied Health Professionals, Athletic Trainers, Nurses, Nurse Practitioners, Pharmacists, Physicians, Physician Assistants, Psychologists, Resident Fellows, Scientist Researcher PhD's, Social Workers, and Students.

LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:

• Evaluate patient care management for patients undergoing Cell Therapy.
• Analyze research topics, clinical trials updates, and publications.
• Review management issues in cell therapy (including patient selection) in accordance with new quality/regulatory and compliance issues. 

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

CREDIT STATEMENT(S)
AMA
The Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

AAPA
Mayo Clinic College of Medicine and Science has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

ANCC
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

IPCE
This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change. 

DISCLOSURE SUMMARY
As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities.  All who are in a position to control the content are required to disclose all financial relationships with any ineligible company.   Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance.

Listed below are individuals with control of the content of this program who have disclosed...

Relevant financial relationship(s) with ineligible companies:
N. Nora Bennani, M.D. - Honoraria - Acrotech Biopharma LLC; Affimed Therapeautics AG; OncoLens; Pfizer, Inc.; Secura Bio, Inc.

Arkadiusz Dudek, M.D., Ph.D. - Honoraria - HiberCell; Lirum Therapeutics; Stock Equity - IGF Oncology; Luminary Therapeutics; Squarex; TTC Oncology; Vanquish Oncology; Board of Directors - TTC Oncology; IGF Oncology; Squarex; New Business Venture - TTC Oncology

Patrick Johnston, M.D.,Ph.D. - Honoraria - Miltenyi Biotec 

Yi Lin, M.D., Ph.D. - Honoraria - Adicet Bio; BMS Global, Inc.; Caribou Biosciences; Fosun Kite Biotechnology; Genentech, Inc.; Genzyme Corporation; Gilead Sciences, Inc.; HOFFMAN-LA ROCHE, LTD; Instil Bio; Janssen Biotech, Inc.; Janssen Global Services, LLC; Janssen Pharmaceuticals, Inc.; Janssen Scientific Affairs, LLC; Kite Pharma, Inc.; Legend Biotech USA Inc.; Nektar Therapeutics; NexImmune; NTx Nature's Toolbox Inc.; Pfizer, Inc.; Regeneron Pharmaceuticals, Inc.; Tessera Biotherapeutics

All relevant financial relationships have been mitigated. 

No relevant financial relationship(s) with ineligible companies:
Liz Fitzgerald, P.A.-C.
Matthew Hathcock
Mira Kohorst, M.D.
Monica Shaw
Ann Strege
Jeanne Voll, APRN, CNS, M.S. 
Madison Koenigs (Coordinator)

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

QUESTIONS?
Contact Madison Koenigs, Department Coordinator